Stock Events

Arrowhead Pharmaceuticals (A2RR34.SA) Q3 2016 Earnings

9AugConfirmed
Q4 2015
Q1 2016
Q2 2016
Q3 2016
-1.59
-1.4
-1.2
-1.01

Details

Expected EPS
-1.162503
Actual EPS
-1.005408
Surprise EPS
0.16
Surprise Percent
+13.51%

Description

Arrowhead Pharmaceuticals (A2RR34.SA) has reported earnings of -1.005408 per share for Q3 2016.

0 Comments

Share your thoughts